Termination Decision: Post-DI Settlement | Sep 4, 2024 | PAPER | BOARD |
Joint Motion to Terminate | Aug 30, 2024 | PAPER | PATENT OWNER |
EX2109 | Aug 30, 2024 | EXHIBIT | PATENT OWNER |
Joint Motion to Treat Settlement Agreement as Confidential | Aug 30, 2024 | PAPER | PATENT OWNER |
ORDER Setting Oral Argument | Aug 26, 2024 | PAPER | BOARD |
Patent Owner's Request for Oral Argument | Aug 7, 2024 | PAPER | PATENT OWNER |
Petitioner's Request for Oral Hearing | Aug 7, 2024 | PAPER | PETITIONER |
Patent Owner's Updated Exhibit List | Jul 29, 2024 | PAPER | PATENT OWNER |
Patent Owner's Sur-Reply | Jul 29, 2024 | PAPER | PATENT OWNER |
2108 - 2024.07.16 Jeffrey Ravetch Deposition Transcript (FULL) | Jul 29, 2024 | EXHIBIT | PATENT OWNER |
Notice of Deposition of J. Ravetch, M.D., Ph.D. | Jul 11, 2024 | PAPER | PATENT OWNER |
SECOND MODIFIED SCHEDULING ORDER 37 C.F.R. § 42.5(c) | Jul 9, 2024 | PAPER | BOARD |
Exhibit 3005 | Jul 9, 2024 | EXHIBIT | BOARD |
Stipulation Modifying Due Dates | Jul 8, 2024 | PAPER | PATENT OWNER |
Petitioner's Reply ISO Petition | Jun 10, 2024 | PAPER | PETITIONER |
Petitioner's Updated Exhibit List | Jun 10, 2024 | PAPER | PETITIONER |
Deposition of Arturo Casadevall, January 24, 2020 | Jun 10, 2024 | EXHIBIT | PETITIONER |
Reply Declaration of Jeffrey V. Ravetch, M.D., Ph.D. | Jun 10, 2024 | EXHIBIT | PETITIONER |
Joint Stipulation Modifying Due Dates | May 14, 2024 | PAPER | PETITIONER |
Patent Owner Response | Mar 13, 2024 | PAPER | PATENT OWNER |
2006 - Dmytrijuk | Mar 13, 2024 | EXHIBIT | PATENT OWNER |
2014 - Greenspan | Mar 13, 2024 | EXHIBIT | PATENT OWNER |
2023 - Arturo Casadevall MD PhD CV | Mar 13, 2024 | EXHIBIT | PATENT OWNER |
2025 - CV Bernhardt Trout 504 | Mar 13, 2024 | EXHIBIT | PATENT OWNER |
2028 - Hill 2007 | Mar 13, 2024 | EXHIBIT | PATENT OWNER |
2029 - 1997 FDA Pts to Consider MAbs | Mar 13, 2024 | EXHIBIT | PATENT OWNER |
2030 - Alexion Press Release 3-16-2007 | Mar 13, 2024 | EXHIBIT | PATENT OWNER |
2031 - Janeway Appx 2005 | Mar 13, 2024 | EXHIBIT | PATENT OWNER |
2033 - Kim 2005 | Mar 13, 2024 | EXHIBIT | PATENT OWNER |
2034 - Hwang 2005 | Mar 13, 2024 | EXHIBIT | PATENT OWNER |
2035 - Shepherd Appx 2000 | Mar 13, 2024 | EXHIBIT | PATENT OWNER |
2036 - Lo 2004 | Mar 13, 2024 | EXHIBIT | PATENT OWNER |
2037 - Welt 2003 | Mar 13, 2024 | EXHIBIT | PATENT OWNER |
2038 - Haller 2008 | Mar 13, 2024 | EXHIBIT | PATENT OWNER |
2039 - Torres 2007 PLOS Article | Mar 13, 2024 | EXHIBIT | PATENT OWNER |
2040 - Torres 2005 | Mar 13, 2024 | EXHIBIT | PATENT OWNER |
2042 - Mathiew 2004 | Mar 13, 2024 | EXHIBIT | PATENT OWNER |
2043 - Andersen 2004 | Mar 13, 2024 | EXHIBIT | PATENT OWNER |
2044 - Chadd 2001 | Mar 13, 2024 | EXHIBIT | PATENT OWNER |
2045 - 2007 USP Dictionary of USAN and Int'l Drug Names | Mar 13, 2024 | EXHIBIT | PATENT OWNER |
2046 - 1997 INN Naming Guidelines | Mar 13, 2024 | EXHIBIT | PATENT OWNER |
2047 - McClean 2005 | Mar 13, 2024 | EXHIBIT | PATENT OWNER |
2049 - HemeOnc Today | Mar 13, 2024 | EXHIBIT | PATENT OWNER |
2050 - Fatimah 2016 | Mar 13, 2024 | EXHIBIT | PATENT OWNER |
2051 - Foote 1992 | Mar 13, 2024 | EXHIBIT | PATENT OWNER |
2052 - Xiang 1995 | Mar 13, 2024 | EXHIBIT | PATENT OWNER |
2053 - Soliris Current Label (06-2019 Label) | Mar 13, 2024 | EXHIBIT | PATENT OWNER |
2054 - Alexion Press Release 9-20-2006 | Mar 13, 2024 | EXHIBIT | PATENT OWNER |
2055 - Alexion Press Release 9-26-2006 | Mar 13, 2024 | EXHIBIT | PATENT OWNER |
2075 - GenScript Final Report | Mar 13, 2024 | EXHIBIT | PATENT OWNER |
2079 - Chang 2002 | Mar 13, 2024 | EXHIBIT | PATENT OWNER |
2080 - Wang 1999 | Mar 13, 2024 | EXHIBIT | PATENT OWNER |
2081 - Hermeling 2004 | Mar 13, 2024 | EXHIBIT | PATENT OWNER |
2082 - Frokjaer | Mar 13, 2024 | EXHIBIT | PATENT OWNER |
2083 - Rosenberg 2006 | Mar 13, 2024 | EXHIBIT | PATENT OWNER |
2084 - ICH Topic Q5C | Mar 13, 2024 | EXHIBIT | PATENT OWNER |
2085 - Q1AR2 Stability Testing Guidance | Mar 13, 2024 | EXHIBIT | PATENT OWNER |
2086 - Stebbings 2013 | Mar 13, 2024 | EXHIBIT | PATENT OWNER |
2088 - Amgen Biosimilar Pipeline | Mar 13, 2024 | EXHIBIT | PATENT OWNER |
2089 - Generium Elizaria | Mar 13, 2024 | EXHIBIT | PATENT OWNER |
2090 - Samsung Bisolimilar Pipeline | Mar 13, 2024 | EXHIBIT | PATENT OWNER |
2091 - Harlowe and Lane 1988 | Mar 13, 2024 | EXHIBIT | PATENT OWNER |
2104 - 2024.02.23 Jeffrey Ravetch Deposition Transcript (FULL) | Mar 13, 2024 | EXHIBIT | PATENT OWNER |
2105 - Declaration of A. Casadevall (for POR) FINAL [809] | Mar 13, 2024 | EXHIBIT | PATENT OWNER |
2106 - 2024.02.20 Cindy Ippoliti Deposition Transcript (FULL) | Mar 13, 2024 | EXHIBIT | PATENT OWNER |
2107 - Declaration for B. Trout (for POR) FINAL [809] | Mar 13, 2024 | EXHIBIT | PATENT OWNER |
EXPUNGED | Feb 12, 2024 | EXHIBIT | BOARD |
FIRST MODIFIED SCHEDULING ORDER | Feb 12, 2024 | PAPER | BOARD |
Ex 3004 | Feb 12, 2024 | EXHIBIT | BOARD |
Patent Owner's Notice of Deposition of Cindy Ippoliti, Pharm.D. | Feb 7, 2024 | PAPER | PATENT OWNER |
Patent Owner's Notice of Deposition of Jeffrey V. Ravetch, M.D., Ph.D. | Feb 7, 2024 | PAPER | PATENT OWNER |
EXPUNGED | Jan 8, 2024 | PAPER | BOARD |
SCHEDULING ORDER | Jan 8, 2024 | PAPER | BOARD |
Granting Institution of Inter Partes Review 35 U.S.C. § 314 | Dec 19, 2023 | PAPER | BOARD |
Patent Owner's Sur-Reply to Petitioner's Reply to Preliminary Response | Dec 1, 2023 | PAPER | PATENT OWNER |
EXPUNGED | Nov 15, 2023 | EXHIBIT | BOARD |
US10590189 | Nov 15, 2023 | EXHIBIT | BOARD |
Petitioner's Reply to Patent Owner's Preliminary Response | Nov 10, 2023 | PAPER | PETITIONER |
Ex. 3001 | Oct 19, 2023 | EXHIBIT | BOARD |
Patent Owner Preliminary Response | Oct 13, 2023 | PAPER | PATENT OWNER |
2005 - SOLIRIS Label | Oct 13, 2023 | EXHIBIT | PATENT OWNER |
2007 - Janeway and Travers | Oct 13, 2023 | EXHIBIT | PATENT OWNER |
2008 - McCloskey | Oct 13, 2023 | EXHIBIT | PATENT OWNER |
2009 - Torres | Oct 13, 2023 | EXHIBIT | PATENT OWNER |
2010 - Janda | Oct 13, 2023 | EXHIBIT | PATENT OWNER |
2011 - Pritsch 1996 | Oct 13, 2023 | EXHIBIT | PATENT OWNER |
2012 - Pritsch 2000 | Oct 13, 2023 | EXHIBIT | PATENT OWNER |
2013 - McLean | Oct 13, 2023 | EXHIBIT | PATENT OWNER |
2015 - Radbruch | Oct 13, 2023 | EXHIBIT | PATENT OWNER |
2017 - Hawkins | Oct 13, 2023 | EXHIBIT | PATENT OWNER |
2018 - Alexion Pharmaceuticals Form 10K | Oct 13, 2023 | EXHIBIT | PATENT OWNER |
2019 - Ricklin and Lambris | Oct 13, 2023 | EXHIBIT | PATENT OWNER |
2020 - Alexion Press Release | Oct 13, 2023 | EXHIBIT | PATENT OWNER |
2021 - Alexion BusinessWire | Oct 13, 2023 | EXHIBIT | PATENT OWNER |
2022 - Arturo Casadevall Declaration | Oct 13, 2023 | EXHIBIT | PATENT OWNER |
2024 - Bernhardt L. Trout PhD Declaration | Oct 13, 2023 | EXHIBIT | PATENT OWNER |
2026 - Michel Nussenzweig Declaration | Oct 13, 2023 | EXHIBIT | PATENT OWNER |
2098 - Harlow and Lane Chapter 1 | Oct 13, 2023 | EXHIBIT | PATENT OWNER |
2100 - Rother 2007 | Oct 13, 2023 | EXHIBIT | PATENT OWNER |
2101 - [1002] - Part 1 - Prosecution History for US Patent 9,718,880 | Oct 13, 2023 | EXHIBIT | PATENT OWNER |
2101 - [1002] - Part 2 - Prosecution History for US Patent 9,718,880 | Oct 13, 2023 | EXHIBIT | PATENT OWNER |
2102 - [1002] - Part 1 - Prosecution History for U.S. Patent No. 10,590,189 B2 | Oct 13, 2023 | EXHIBIT | PATENT OWNER |
2102 - [1002] - Part 2 - Prosecution History for U.S. Patent No. 10,590,189 B2 | Oct 13, 2023 | EXHIBIT | PATENT OWNER |
2102 - [1002] - Part 3 - Prosecution History for U.S. Patent No. 10,590,189 B2 | Oct 13, 2023 | EXHIBIT | PATENT OWNER |
2102 - [1002] - Part 4 - Prosecution History for U.S. Patent No. 10,590,189 B2 | Oct 13, 2023 | EXHIBIT | PATENT OWNER |
2102 - [1002] - Part 5 - Prosecution History for U.S. Patent No. 10,590,189 B2 | Oct 13, 2023 | EXHIBIT | PATENT OWNER |
2102 - [1002] - Part 6 - Prosecution History for U.S. Patent No. 10,590,189 B2 | Oct 13, 2023 | EXHIBIT | PATENT OWNER |
2102 - [1002] - Part 7 - Prosecution History for U.S. Patent No. 10,590,189 B2 | Oct 13, 2023 | EXHIBIT | PATENT OWNER |
2102 - [1002] - Part 8 - Prosecution History for U.S. Patent No. 10,590,189 B2 | Oct 13, 2023 | EXHIBIT | PATENT OWNER |
2102 - [1002] - Part 9 - Prosecution History for U.S. Patent No. 10,590,189 B2 | Oct 13, 2023 | EXHIBIT | PATENT OWNER |
2102 - [1002] - Part 10 - Prosecution History for U.S. Patent No. 10,590,189 B2 | Oct 13, 2023 | EXHIBIT | PATENT OWNER |
2102 - [1002] - Part 11 - Prosecution History for U.S. Patent No. 10,590,189 B2 | Oct 13, 2023 | EXHIBIT | PATENT OWNER |
2102 - [1002] - Part 12 - Prosecution History for U.S. Patent No. 10,590,189 B2 | Oct 13, 2023 | EXHIBIT | PATENT OWNER |
2102 - [1002] - Part 13 - Prosecution History for U.S. Patent No. 10,590,189 B2 | Oct 13, 2023 | EXHIBIT | PATENT OWNER |
2102 - [1002] - Part 14 - Prosecution History for U.S. Patent No. 10,590,189 B2 | Oct 13, 2023 | EXHIBIT | PATENT OWNER |
2103 - [1002] - Prosecution History for US Patent No. 9,725,504 B2 | Oct 13, 2023 | EXHIBIT | PATENT OWNER |
NOTICE OF FILING DATE ACCORDED TO PETITION AND TIME FOR FILING PATENT OWNER PRELIMINARY RESPONSE | Jul 14, 2023 | PAPER | BOARD |
Notice : Mandatory Notice | Jul 6, 2023 | PAPER | PATENT OWNER |
Notice : Power of Attorney | Jul 6, 2023 | PAPER | PATENT OWNER |
Notice : Power of Attorney | Jun 16, 2023 | PAPER | PETITIONER |
Petition : as filed | Jun 16, 2023 | PAPER | PETITIONER |
U.S. Patent No. 10,703,809 B1 issued to Leonard Bell et al. | Jun 16, 2023 | EXHIBIT | PETITIONER |
Prosecution History for US Patent No. 10,703,809 B1 | Jun 16, 2023 | EXHIBIT | PETITIONER |
Declaration of Jeffrey V. Ravetch M.D. Ph.D. | Jun 16, 2023 | EXHIBIT | PETITIONER |
U.S. Pat. Appl. Publ. 2003/0232972 A1 issued Katherine S Bowdish | Jun 16, 2023 | EXHIBIT | PETITIONER |
U.S. Patent No. 6, 355,245 B1 issued to Mark J. Evans | Jun 16, 2023 | EXHIBIT | PETITIONER |
Mueller, Humanized Porcine...34 Molecular Immunology, 441 (1997) | Jun 16, 2023 | EXHIBIT | PETITIONER |
US Pat. Appl. Publ. 2005/0191298 A1 issued to Leonard Bell | Jun 16, 2023 | EXHIBIT | PETITIONER |
Tacken, Effective induction of naive and recall...106 Blood 1278 (2005) | Jun 16, 2023 | EXHIBIT | PETITIONER |
WO 97/11971 issued to John P. Mueller | Jun 16, 2023 | EXHIBIT | PETITIONER |
Thomas, Inhibition of Complement....Molecular Imm. 1389 (1996) | Jun 16, 2023 | EXHIBIT | PETITIONER |
Hillmen, Effect of Eculizumab...350 N.Engl.J.Med. 552 (2204) | Jun 16, 2023 | EXHIBIT | PETITIONER |
Hill, Abstract #2823....104 Blood 772a (2004) | Jun 16, 2023 | EXHIBIT | PETITIONER |
Hill, Sustained response and long-term safety...106 Blood 2559 (2005) | Jun 16, 2023 | EXHIBIT | PETITIONER |
Hillmen, The Complement Inhibitor....355 N.Engl.J.Med. 1233 (2006) | Jun 16, 2023 | EXHIBIT | PETITIONER |
Young, Abstract #971....108 Blood 290a (2006) | Jun 16, 2023 | EXHIBIT | PETITIONER |
Hillmen, Abstract #154....100 Blood 44a (2002) | Jun 16, 2023 | EXHIBIT | PETITIONER |
Hillmen, Abstract #1858...102 Blood 509a (2003) | Jun 16, 2023 | EXHIBIT | PETITIONER |
Excerpts from Recommended INN List 49....17 WHO Drug Info 115, WHO (2003) | Jun 16, 2023 | EXHIBIT | PETITIONER |
Guidleines on the Use of INNs....WHO, Geneva (1997) | Jun 16, 2023 | EXHIBIT | PETITIONER |
Alexion Press Release, Alexion Issued Key C5....March 15, 2002 | Jun 16, 2023 | EXHIBIT | PETITIONER |
WO 2005/007809 A2 issued to Russell P. Rother | Jun 16, 2023 | EXHIBIT | PETITIONER |
WO 2005/110481 A2 issued to Russell P. Rother | Jun 16, 2023 | EXHIBIT | PETITIONER |
Kaplan, Eculizumab Alexion, 3 Curr. Opin. Investig. Drugs 1017 (2002) | Jun 16, 2023 | EXHIBIT | PETITIONER |
Amgen v. Alexion, IPR2019-00739 #15 Decision-Institution August 30, 2019 | Jun 16, 2023 | EXHIBIT | PETITIONER |
IPR2019-00741, Termination, #48 | Jun 16, 2023 | EXHIBIT | PETITIONER |
Opposition File History for EP 1 720 571 B1 | Jun 16, 2023 | EXHIBIT | PETITIONER |
File History for EP 3 167 888 | Jun 16, 2023 | EXHIBIT | PETITIONER |
Excerpt from File History US Pat Appl 11/127,438, Amdmt in Resp NFOA 8/2/11 | Jun 16, 2023 | EXHIBIT | PETITIONER |
Appl for Extension of Patent Term - 6,355,245 5/11/2007 | Jun 16, 2023 | EXHIBIT | PETITIONER |
Certificate Extending Patent Term - 6,355,245 6/11/2010 | Jun 16, 2023 | EXHIBIT | PETITIONER |
Excerpt from File History US Pat 10,590,809 IDS dated 5/31/2019 | Jun 16, 2023 | EXHIBIT | PETITIONER |
Yoo, Human IgG2 Can Form Covalent Dimers, 170 J.Immunol. 3134 (2003) | Jun 16, 2023 | EXHIBIT | PETITIONER |
Excerpt from File History US Pat 10,590,809 Non Final Rejection 6/11/2019 | Jun 16, 2023 | EXHIBIT | PETITIONER |
Excerpt from File History U.S. Pat. 10,590,809 Ntc of Allowance 1/22/2020 | Jun 16, 2023 | EXHIBIT | PETITIONER |
Excerpt from File History US Pat 10,590,809 Amdmt in Resp to NFOA 12/11/19 | Jun 16, 2023 | EXHIBIT | PETITIONER |
Wypych, Human IgG2 Antibodies...283 J.Biol.Chem. 16194 (2008) | Jun 16, 2023 | EXHIBIT | PETITIONER |
Bournazos, Fc-optimized antibodies....588 Nature 485 (2020) | Jun 16, 2023 | EXHIBIT | PETITIONER |
Bournazos, Human IgG Fc domain...124 J.Clinical Investigation 725 (2014) | Jun 16, 2023 | EXHIBIT | PETITIONER |
Baudino, Impact of a Three Amino Acid...181 J.Immunology 4107 (2008) | Jun 16, 2023 | EXHIBIT | PETITIONER |
Takai, FcR y Chain Deletion...76 Cell 519 (1994) | Jun 16, 2023 | EXHIBIT | PETITIONER |
Nimmerjahn, Fcy receptors...8 Nat. Rev. Immunol. 34 (2008) | Jun 16, 2023 | EXHIBIT | PETITIONER |
Ravetch, Fc Receptors, 9 Annu. Rev. Immunol. 457 (1991) | Jun 16, 2023 | EXHIBIT | PETITIONER |
US Pat Appl Publ 2005/0271660 A1 issued to Yi Wang | Jun 16, 2023 | EXHIBIT | PETITIONER |
Janeway, Chapter 1...Chapter 3...Immunobio..pp. 1-34, 93-122 5th ed. 2001 | Jun 16, 2023 | EXHIBIT | PETITIONER |
Excerpts from Juo, Concise Dict. of Biomed. and Molec. Biology 2d ed. 2001 | Jun 16, 2023 | EXHIBIT | PETITIONER |
Volkel, Optimized linker...14 Protein Eng. 815 (2001) | Jun 16, 2023 | EXHIBIT | PETITIONER |
Lobo, Antibody Pharma...93 J. of Pharma. Sciences 2645 (2004) | Jun 16, 2023 | EXHIBIT | PETITIONER |
Lipman, Monoclonal Versus Polyclonal...46 ILAR J. 258 (2005) | Jun 16, 2023 | EXHIBIT | PETITIONER |
Lo, Chapter 7...V.248...pp. 135-159 (2004) | Jun 16, 2023 | EXHIBIT | PETITIONER |
Reichmann, Reshaping human antibodies for therapy, 332 Nature 323 (1988) | Jun 16, 2023 | EXHIBIT | PETITIONER |
Reichert, Marketed therapeutic antibodies compendium, 4 mAbs 413 (2012) | Jun 16, 2023 | EXHIBIT | PETITIONER |
Alberts, Chapter 12...Molecular Bio of the Cell, pp. 551-98 (1994) | Jun 16, 2023 | EXHIBIT | PETITIONER |
Adderson, Immunoglobulin Light Chain....89 J. Clin. Invest. 729 (1992) | Jun 16, 2023 | EXHIBIT | PETITIONER |
Genentech Avastin 2004 Package Insert | Jun 16, 2023 | EXHIBIT | PETITIONER |
Millennium Campath 2001 Package Insert | Jun 16, 2023 | EXHIBIT | PETITIONER |
ImClone Erbitux 2004 Package Insert | Jun 16, 2023 | EXHIBIT | PETITIONER |
Genentech Herceptin 1998 Package Insert | Jun 16, 2023 | EXHIBIT | PETITIONER |
Centocor Remicade 1998 Package Insert | Jun 16, 2023 | EXHIBIT | PETITIONER |
Genentech Rituxan 1997 Package Insert | Jun 16, 2023 | EXHIBIT | PETITIONER |
Daugherty, Formulation and delivery...58 Adv. Drug Delivery Rev. 686 (2006) | Jun 16, 2023 | EXHIBIT | PETITIONER |
Declaration of Cindy Ippoliti, Pharm.D. | Jun 16, 2023 | EXHIBIT | PETITIONER |
Note of Guidance on Excipients, Antioxidants and Antimicrobial....(2003) | Jun 16, 2023 | EXHIBIT | PETITIONER |
Excerpt from The Merck Manual (17th ed. 1999) | Jun 16, 2023 | EXHIBIT | PETITIONER |
Health, U.S. 2005 with Chartbook and Trends... | Jun 16, 2023 | EXHIBIT | PETITIONER |
Excerpt from File History US Pat 9,718,880 Resp to NFOA 5/12/2017 | Jun 16, 2023 | EXHIBIT | PETITIONER |
Excerpt from File History Pat. 9,718,880, Decl of Dr. Laural Boone 5/11/17 | Jun 16, 2023 | EXHIBIT | PETITIONER |
Brown, The Correlation between Fatigue....103 Cancer 377 (2004) | Jun 16, 2023 | EXHIBIT | PETITIONER |